Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Detaylı Bibliyografya
Yazar:	Tania, Umme
Diğer Yazarlar:	Khan, Tanisha
Materyal Türü:	Tez
Dil:	English
Baskı/Yayın Bilgisi:	Brac University 2023
Konular:	Biologics Biosimilars Bevacizumab Non-small cell lung cancer Regulatory frameworks Targeted therapy Lungs > Cancer
Online Erişim:	http://hdl.handle.net/10361/18736

Benzer Materyaller

A review on targeted therapies for lung cancer
Yazar:: Ashraf, Anushey
Baskı/Yayın Bilgisi: (2023)

Molecules associated with the development of lung cancer
Yazar:: Rahman, Adree, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Yazar:: Paul, Pulock
Baskı/Yayın Bilgisi: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
Yazar:: Jeba, Joynob
Baskı/Yayın Bilgisi: (2017)

Potential of liposomes for the treatment of lung cancer- a review
Yazar:: Mim, Shanzida
Baskı/Yayın Bilgisi: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
Yazar:: Rahman, Tasnim
Baskı/Yayın Bilgisi: (2024)

Biosimilar in lymphoma treatment
Yazar:: Tanisha, Mehrin Haque
Baskı/Yayın Bilgisi: (2021)

A review on recent advances in drugs for lung cancer treatment
Yazar:: Noor, Fouzia
Baskı/Yayın Bilgisi: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
Yazar:: Hoque, Ismoth Ara
Baskı/Yayın Bilgisi: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Yazar:: Razna, Amrin Islam
Baskı/Yayın Bilgisi: (2019)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
Yazar:: Bristy, Israt Zerin
Baskı/Yayın Bilgisi: (2021)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
Yazar:: Shabnam, Musharrat
Baskı/Yayın Bilgisi: (2018)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
Yazar:: Pial, Sazia Afrin
Baskı/Yayın Bilgisi: (2018)

Immunotherapy in the Management of Lung Cancer
Yazar:: Tasnim, Humayra
Baskı/Yayın Bilgisi: (2022)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
Yazar:: Zangmo, Thinley
Baskı/Yayın Bilgisi: (2024)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
Yazar:: Nandy, Aditi
Baskı/Yayın Bilgisi: (2022)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Yazar:: Flora, Sanzida Alam
Baskı/Yayın Bilgisi: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
Yazar:: Alam, Kazi Tasnuva
Baskı/Yayın Bilgisi: (2022)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
Yazar:: Das, Reshita
Baskı/Yayın Bilgisi: (2024)

Concepts and challenges of biosimilars to mitigate the oncology drug expenses
Yazar:: Tania, Umme
Baskı/Yayın Bilgisi: (2021)

Lung cancer detection and classification using machine learning
Yazar:: Arefin, Mahbubul, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
Yazar:: Mukti, Roushney Fatima, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Yazar:: Karim, Samia Binte
Baskı/Yayın Bilgisi: (2024)

Stem cells as therapeutic carrier in cancer treatment
Yazar:: Anika, Mysha Yeasmin
Baskı/Yayın Bilgisi: (2022)

SIRT6 and cancer stem cells: is there any implication?
Yazar:: Sarker, Tanosi
Baskı/Yayın Bilgisi: (2022)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
Yazar:: Nawar, Anika
Baskı/Yayın Bilgisi: (2019)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
Yazar:: Nahar, Kamrun
Baskı/Yayın Bilgisi: (2023)

Biologics and Biosimilars as Treatment Options for Psoriasis
Yazar:: Moya, Amena Khatun
Baskı/Yayın Bilgisi: (2023)

Targeting BRAFV600E in the treatment of CRC
Yazar:: Roja, Mashwiyat Samrin
Baskı/Yayın Bilgisi: (2024)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
Yazar:: Pecorino, Lauren
Baskı/Yayın Bilgisi: (2012)

Trend in approval of targeted biologics in the last two decades
Yazar:: Siddika, Khadiza
Baskı/Yayın Bilgisi: (2024)

Dendritic cell vaccine for the treatment of cancer
Yazar:: Haque, Tanzila
Baskı/Yayın Bilgisi: (2023)

Biosimilars: A revolution for biologics in the pharmaceutical industry
Yazar:: Moreino, Shannon Sherwin
Baskı/Yayın Bilgisi: (2018)

Stem cell in cancer disease cure vs cause
Yazar:: Chowdhury, Marisha Mansur
Baskı/Yayın Bilgisi: (2023)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
Yazar:: F. S. Amaral, André, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

RIPK pathway, as a potential target, for cancer treatment - a review
Yazar:: Jahan, Nusrat
Baskı/Yayın Bilgisi: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
Yazar:: Emon, Kamrul Hasan
Baskı/Yayın Bilgisi: (2022)

CAR-T cell Therapy in B-cell Lymphoma
Yazar:: Faruk, Asef
Baskı/Yayın Bilgisi: (2020)

Biosimilar insulins: a potential option in the treatment of Diabetes
Yazar:: Tabassum, Turana
Baskı/Yayın Bilgisi: (2022)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
Yazar:: Auvy, Akib Al Mahmud, ve diğerleri
Baskı/Yayın Bilgisi: (2023)